• Exchange: ASE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Antisense Therapeutics Ltd

+ Add to Watchlist


0.0990 AUD 0.0010 1.00%

As of 22:41:42 ET on 01/22/2015.

Snapshot for Antisense Therapeutics Ltd (ANP)

Open: 0.1000 Day's Range: 0.0990 - 0.1000 Volume: 121,500
Previous Close: 0.1000 52wk Range: 0.0820 - 0.2350 1-Yr Rtn: -29.29%

Stock Chart for ANP

No chart data available.
  • ANP:AU 0.0990
  • 1D
  • 1M
  • 1Y
Interactive ANP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ANP

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. AS51 -
Earnings Per Share (ttm) -0.0209
Est. EPS -
Est. PEG Ratio -
Market Cap (M AUD) 15.99
Shares Outstanding (M) 161.49
30 Day Average Volume 95,258
Price/Book (mrq) 6.8358
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/24/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ANP

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for ANP

Antisense Therapeutics Limited develops and markets drugs for treatment of diseases like psoriasis, multiple sclerosis, autoimmune, cancer, metabolic and cardiovascular. The drugs are based on small synthetic genetic molecules. The Company has collaboration with Isis Pharmaceuticals in the United States, which provides the Company access to drug development technology.

Mark P DiamondCEO/Managing DirectorPhillip HainsCFO/Secretary
More Company Profile & Key Executives for ANP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil